CSCIFCOSCIENS Biopharma Inc

About COSCIENS Biopharma Inc (CSCIF)

COSCIENS Biopharma Inc (CSCIF) is a company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the OTCQB tier.

COSCIENS Biopharma Inc. (the "Company"), formerly Aeterna Zentaris Inc., is a Life Science company developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. Such products being produced using the Company's proprietary technologies. The Company's patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a unique and disruptive technology that generates high-value yields of active ingredients from natural based resources for use in novel cosmeceutical, nutraceutical and therapeutics products. The Company's two value-driving products, oat beta glucan and avenanthramides, are found in many household name cosmetic and personal care brands. These products are manufactured from the Company's proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. The Company is also dedicated to the development of its therapeutic assets and has established a development pipeline to potentially address unmet medical needs across a number of indications, including potential treatment of inflammation and immune-based diseases.

Products and services

Facilities related to the extrications of active ingredient, see above for more details.

CSCIF key facts

Ticker symbol

CSCIF

Market tier

OTCQB

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

1990

Employees

25

Estimated market cap

$6.84M (as of Jan 12, 2026)

Shares outstanding

3,183,330

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

COSCIENS Biopharma Inc leadership

• Peter H. Puccetti — CEO
• Giuliano La Fratta — CFO

Explore more: OTCQB stocks · OTC stocks starting with C